403 Results for "

Phosphodiesterase (PDE)

" in MedChemExpress (MCE) Product Catalog:
Products (403)

403 Results for "Phosphodiesterase (PDE)" in MCE Product Catalog:

75
75 Publications Verification
Cat. No.: HY-12318
CAS No.: 28822-58-4
Purity:  99.99%
Synonyms: 3-Isobutyl-1-methylxanthine; Isobutylmethylxanthine
Research Areas:  

Inflammation/Immunology

IBMX is a broad-spectrum phosphodiesterase (PDE) inhibitor, with IC50s of 6.5, 26.3 and 31.7 μM for PDE3, PDE4 and PDE5, respectively.
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-15025A
CAS No.: 171599-83-0
Purity:  99.86%
Synonyms: UK-92480 citrate
Sildenafil citrate is a potent phosphodiesterase type 5 (PDE5) inhibitor with IC50 of 5.22 nM.
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-15025
CAS No.: 139755-83-2
Purity:  99.90%
Synonyms: UK-92480
Sildenafil (UK-92480) is a potent phosphodiesterase type 5 (PDE5) inhibitor with an IC50 of 5.22 nM.
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-B0140
CAS No.: 317-34-0
Aminophylline is a competitive and non-selective phosphodiesterase (PDE) inhibitor. Aminophylline is a competitive adenosine receptor antagonist. Aminophylline has apulmonary vasodilator action as well as a bronchodilator action and has the potential for asthma research .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-B0715
CAS No.: 6493-05-6
Synonyms: BL-191; PTX; Oxpentifylline
Pentoxifylline (BL-191), a haemorheological agent, is an orally active non-selective phosphodiesterase (PDE) inhibitor, with immune modulation, anti-inflammatory, hemorheological, anti-fibrinolytic and anti-proliferation effects. Pentoxifylline can be used for the research of peripheral vascular disease, cerebrovascular disease and a number of other conditions involving a defective regional microcirculation .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-B0809
CAS No.: 58-55-9
Synonyms: 1,3-Dimethylxanthine; Theo-24
Theophylline (1,3-Dimethylxanthine) is a potent phosphodiesterase (PDE) inhibitor, adenosine receptor antagonist, and histone deacetylase (HDAC) activator. Theophylline (1,3-Dimethylxanthine) inhibits PDE3 activity to relax airway smooth muscle. Theophylline (1,3-Dimethylxanthine) has anti-inflammatory activity by increase IL-10 and inhibit NF-κB into the nucleus. Theophylline (1,3-Dimethylxanthine) induces apoptosis. Theophylline (1,3-Dimethylxanthine) can be used for asthma and chronic obstructive pulmonary disease (COPD) research .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-B0312
CAS No.: 58-32-2
Dipyridamole is an orally active phosphodiesterase (PDE) inhibitor. Dipyridamole also is an antiplatelet agent used in secondary prophylaxis against stroke. Dipyridamole can induce cancer cell-specific apoptosis .
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-B0809A
CAS No.: 5967-84-0
Synonyms: 1,3-Dimethylxanthine monohydrate; Theo-24 monohydrate
Theophylline (1,3-Dimethylxanthine) monohydrate is a potent phosphodiesterase (PDE) inhibitor, adenosine receptor antagonist, and histone deacetylase (HDAC) activator. Theophylline (1,3-Dimethylxanthine) monohydrate inhibits PDE3 activity to relax airway smooth muscle. Theophylline (1,3-Dimethylxanthine) monohydrate has anti-inflammatory activity by increase IL-10 and inhibit NF-κB into the nucleus. Theophylline (1,3-Dimethylxanthine) monohydrate induces apoptosis. Theophylline (1,3-Dimethylxanthine) monohydrate can be used for asthma and chronic obstructive pulmonary disease (COPD) research .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-12085
CAS No.: 608141-41-9
Purity:  99.91%
Synonyms: CC-10004
Apremilast (CC-10004) is an orally available inhibitor of type-4 cyclic nucleotide phosphodiesterase (PDE-4) with an IC50 of 74 nM. Apremilast inhibits TNF-α release by lipopolysaccharide (LPS) with an IC50 of 104 nM .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-B0763
CAS No.: 50847-11-5
Synonyms: KC-404; AV-411; MN-166
Research Areas:  

Inflammation/Immunology Cancer

Ibudilast (KC-404; AV-411; MN-166) is a cyclic AMP phosphodiesterase (PDE) inhibitor. Ibudilast has platelet anti-aggregatory effects. Ibudilast can be used for the research of asthma for its inhibitory effects on tracheal smooth muscle contractility. Ibudilast may be a useful neuroprotective and anti-dementia agent counteracting neurotoxicity in activated microglia .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-13295
CAS No.: 42971-09-5
Purity:  99.57%
Synonyms: Ethyl apovincaminate
Vinpocetine (Ethyl apovincaminate) is a derivative of the alkaloid Vincamine that blocks voltage-gated Na + channels. The IC50 value of Vinpocetine on direct IKK inhibition in the cell-free system is 17.17 μM. Vinpocetine is a phosphodiesterase (PDE) inhibitor and inhibits NF-κB-dependent inflammatory responses by directly targeting IκB kinase complex (IKK), and has been widely used for the treatment of cerebrovascular disorders .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-17464
CAS No.: 73963-72-1
Synonyms: OPC 13013
Cilostazol (OPC 13013) is a potent and selective inhibitor of phosphodiesterase (PDE) 3A, the isoform of PDE 3 in the cardiovascular system, with an IC50 of 0.2 μM .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-B0442
CAS No.: 224785-90-4
Vardenafil is a selective and orally active inhibitor of phosphodiesterase-5 (PDE5), with an IC50 of 0.7 nM. Vardenafil shows inhibitory towards PDE1, PDE6 with IC50s of 180 nM, and 11 nM, while IC50s are >1000 nM for PDE3 and PDE4 . Vardenafil competitively inhibits cyclic guanosine monophosphate (cGMP) hydrolysis and thus increases cGMP levels . Vardenafil can be used for the research of erectile dysfunction, hepatitis, diabetes [1]-[6].
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-B0442A
CAS No.: 224785-91-5
Vardenafil hydrochloride is a selective and orally active inhibitor of phosphodiesterase-5 (PDE5), with an IC50 of 0.7 nM. Vardenafil hydrochloride shows inhibitory towards PDE1, PDE6 with IC50s of 180 nM, and 11 nM, while IC50s are >1000 nM for PDE3 and PDE4 . Vardenafil hydrochloride competitively inhibits cyclic guanosine monophosphate (cGMP) hydrolysis and thus increases cGMP levels . Vardenafil hydrochloride can be used for the research of erectile dysfunction, hepatitis, diabetes [1]-[6].
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-B0442B
CAS No.: 330808-88-3
Vardenafil hydrochloride trihydrate is a selective and orally active inhibitor of phosphodiesterase-5 (PDE5), with an IC50 of 0.7 nM. Vardenafil hydrochloride trihydrate shows inhibitory towards PDE1, PDE6 with IC50s of 180 nM, and 11 nM, while IC50s are >1000 nM for PDE3 and PDE4 . Vardenafil hydrochloride trihydrate competitively inhibits cyclic guanosine monophosphate (cGMP) hydrolysis and thus increases cGMP levels . Vardenafil hydrochloride trihydrate can be used for the research of erectile dysfunction, hepatitis, diabetes [1]-[6].
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-103160A
CAS No.: 58337-38-5
Purity:  99.67%
EHNA hydrochloride is a potent and selective dual inhibitor of cyclic nucleotide phosphodiesterase 2 (PDE2)(IC50=4 μM) and adenosine deaminase (ADA). EHNA hydrochloride exerts a concentration inhibition of the cGMP-stimulated PDE II (cGs-PDE)(IC50:0.8 μM (human), 2 μM (porcine myocardium)), but has smaller inhibitory effect on the unstimulated PDE2 activity. EHNA hydrochloride play roles in mediating diverse pharmacological responses, including antiviral, antitumour and antiarrhythmic effects .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-122942
CAS No.: 56317-21-6
Purity:  98.90%
Moracin M is a phenolic component that can be isolated from Mori Cortex, is a potent phosphodiesterase-4 (PDE4) inhibitor with IC50 values of 2.9, 4.5, >40, and >100 μM for PDE4D2, PDE4B2, PDE5A1, and PDE9A2, respectively. Moracin M has anti-inflammatory activity .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-W028690
CAS No.: 328104-79-6
Research Areas:  

Cancer

DNMDP, a phosphodiesterase 3A (PDE3A) inhibitor, is a potent and selective cancer cell cytotoxic agent. DNMDP binding to PDE3A promotes an interaction between PDE3A and Schlafen 12 (SLFN12). DNMDP shows clear cell-selective cytotoxicity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-117571
CAS No.: 1606974-33-7
Purity:  99.50%
Synonyms: BPN14770
Research Areas:  

Neurological Disease

Zatolmilast (BPN14770) is a selective phosphodiesterase 4D (PDE4D) allosteric inhibitor with IC50s of 7.8 nM and 7.4 nM for PDE4D7 and PDE4D3, respectively .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-109085
CAS No.: 937782-05-3
Purity:  99.63%
Synonyms: OPA-15406
Difamilast (OPA-15406) is a topical, selective and nonsteroidal phosphodiesterase-4 (PDE4) inhibitor with particularly efficient inhibition of subtype B (IC50=11.2 nM). Difamilast can be used for the research of mild to moderate atopic dermatitis (AD) .
loading...
    loading...